Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells

por Pereboeva, Larisa, Hubbard, Meredith, Goldman, Frederick D., Westin, Erik R.
Publicado 2016

CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response

por Westin, Erik R, Khodadadi-Jamayran, Alireza, Pham, Linh K, Tung, Moon Ley, Goldman, Frederick D
Publicado 2023

Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction

por Li, Chao, Ding, Lei, Sun, Chiao-Wang, Wu, Li-Chen, Zhou, Dewang, Pawlik, Kevin M., Khodadadi-Jamayran, Alireza, Westin, Erik, Goldman, Frederick D., Townes, Tim M.
Publicado 2016

The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation

por Wang, Hao, Berger, Kristin N., Miller, Elizabeth L., Fu, Wei, Broglie, Larisa, Goldman, Frederick D., Konig, Heiko, Lim, Su Jin, Berg, Arthur S., Talano, Julie-An, Comito, Melanie A., Farag, Sherif S., Pu, Jeffrey J.
Publicado 2023

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients

por Agarwal, Suneet, Loh, Yuin-Han, McLoughlin, Erin M., Huang, Junjiu, Park, In-Hyun, Miller, Justine D., Huo, Hongguang, Okuka, Maja, dos Reis, Rosana Maria, Loewer, Sabine, Ng, Huck-Hui, Keefe, David L., Goldman, Frederick D., Klingelhutz, Aloysius J., Liu, Lin, Daley, George Q.
Publicado 2010

Genotype-phenotype association and variant characterization in Diamond Blackfan anemia caused by pathogenic variants in RPL35A

por Gianferante, D. Matthew, Wlodarski, Marcin W., Atsidaftos, Evangelia, Da Costa, Lydie, Delaporta, Polyxeni, Farrar, Jason E., Goldman, Frederick D., Hussain, Maryam, Kattamis, Antonis, Leblanc, Thierry, Lipton, Jeffrey M., Niemeyer, Charlotte M., Pospisilova, Dagmar, Quarello, Paola, Ramenghi, Ugo, Sankaran, Vijay G., Vlachos, Adrianna, Volejnikova, Jana, Alter, Blanche P., Savage, Sharon A., Giri, Neelam
Publicado 2020

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

por Chan, Alice Y., Leiding, Jennifer W., Liu, Xuerong, Logan, Brent R., Burroughs, Lauri M., Allenspach, Eric J., Skoda-Smith, Suzanne, Uzel, Gulbu, Notarangelo, Luigi D., Slatter, Mary, Gennery, Andrew R., Smith, Angela R., Pai, Sung-Yun, Jordan, Michael B., Marsh, Rebecca A., Cowan, Morton J., Dvorak, Christopher C., Craddock, John A., Prockop, Susan E., Chandrakasan, Shanmuganathan, Kapoor, Neena, Buckley, Rebecca H., Parikh, Suhag, Chellapandian, Deepak, Oshrine, Benjamin R., Bednarski, Jeffrey J., Cooper, Megan A., Shenoy, Shalini, Davila Saldana, Blachy J., Forbes, Lisa R., Martinez, Caridad, Haddad, Elie, Shyr, David C., Chen, Karin, Sullivan, Kathleen E., Heimall, Jennifer, Wright, Nicola, Bhatia, Monica, Cuvelier, Geoffrey D. E., Goldman, Frederick D., Meyts, Isabelle, Miller, Holly K., Seidel, Markus G., Vander Lugt, Mark T., Bacchetta, Rosa, Weinacht, Katja G., Andolina, Jeffrey R., Caywood, Emi, Chong, Hey, de la Morena, Maria Teresa, Aquino, Victor M., Shereck, Evan, Walter, Jolan E., Dorsey, Morna J., Seroogy, Christine M., Griffith, Linda M., Kohn, Donald B., Puck, Jennifer M., Pulsipher, Michael A., Torgerson, Troy R.
Publicado 2020